Share Price and Basic Stock Data
Last Updated: January 10, 2026, 7:30 am
| PEG Ratio | 7.15 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Timken India Ltd operates in the bearings industry, reported a current price of ₹3,032 and a market capitalization of ₹22,804 Cr. Over the last fiscal year ending March 2023, the company recorded sales of ₹2,807 Cr, marking a significant increase from ₹2,203 Cr in the previous year. The momentum continued into the current fiscal year, with sales reaching ₹2,910 Cr by March 2024. The growth trajectory appears robust, as the trailing twelve months (TTM) sales stood at ₹3,193 Cr. Quarterly sales have shown fluctuations, with the highest quarterly sales of ₹898 Cr reported in March 2024, while the lowest was ₹609 Cr in December 2022. This indicates a recovery trend post-pandemic, supported by a diversified customer base and strategic market positioning. The company’s operational performance aligns with sector trends, where demand for bearings remains stable due to diverse applications across industries, including automotive and manufacturing.
Profitability and Efficiency Metrics
Timken India Ltd has demonstrated solid profitability with a reported net profit of ₹455 Cr for the fiscal year ending March 2025, compared to ₹391 Cr in the previous year. The operating profit margin (OPM) stood at 19% for FY 2025, slightly lower than the 20% recorded in FY 2023, which indicates a stable but slightly contracting margin environment. The return on equity (ROE) was reported at 17%, while the return on capital employed (ROCE) was recorded at 20.9%, reflecting efficient utilization of equity and capital. The interest coverage ratio (ICR) was an impressive 149.64x, underscoring the company’s strong ability to cover its interest obligations. This level of profitability and efficiency is favorable compared to industry averages, as the bearings sector typically faces pressures from raw material costs and competitive pricing. The company’s operational efficiency is further highlighted by a cash conversion cycle (CCC) of 129 days, indicating effective management of receivables and inventory.
Balance Sheet Strength and Financial Ratios
Timken India Ltd’s balance sheet exhibits strong financial health, with total assets reported at ₹3,425 Cr and total liabilities at ₹3,425 Cr as of March 2025, resulting in a debt-free status with borrowings only at ₹15 Cr. The company’s reserves have increased to ₹2,693 Cr, reflecting a solid retention of earnings and a strategic approach to reinvestment. The price-to-book value (P/BV) ratio stood at 7.27x, indicating premium valuations in comparison to the book value per share of ₹378.21. The current ratio was reported at 3.82, significantly above the typical industry benchmark of 1.5, showing strong liquidity. However, the inventory turnover ratio of 4.80 indicates that inventory management will require attention, as it suggests that inventory may not be moving as quickly as desired. Overall, the financial ratios highlight a strong position, though the relatively high P/BV reflects investor confidence rather than operational performance alone.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Timken India Ltd reveals a stable investor base, with promoters holding 51.05% of the equity, down from 67.80% in December 2022. Foreign Institutional Investors (FIIs) have increased their stake to 7.39%, while Domestic Institutional Investors (DIIs) hold 29.72%. The public shareholding is at 11.84%, indicating a healthy distribution of shares. The number of shareholders has increased to 76,566, reflecting growing interest in the company. This shift in shareholding dynamics may suggest a gradual move towards increased institutional participation, which often correlates with enhanced corporate governance standards and operational transparency. The declining promoter stake could be indicative of a strategic decision to diversify ownership, potentially attracting more institutional investors. Overall, the shareholding pattern supports a positive outlook for investor confidence, particularly in light of the company’s strong financial performance and market position.
Outlook, Risks, and Final Insight
Looking ahead, Timken India Ltd is well-positioned to capitalize on the growing demand in the bearings market, driven by industrial growth and infrastructure development. However, risks such as fluctuating raw material costs and potential supply chain disruptions could impact profit margins. The company must also navigate competitive pressures from both domestic and international players. Additionally, while the financial metrics indicate a strong operational foundation, the high P/BV ratio may pose a risk if market sentiment shifts. Future performance will depend on maintaining operational efficiencies and managing costs effectively. If the company can leverage its strong balance sheet to invest in innovation and expand its product offerings, it may enhance its market share. Conversely, failure to address inventory management issues or external market challenges could hinder growth prospects. Overall, a balanced approach to growth and risk management will be crucial for sustaining momentum in the coming years.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Galaxy Bearings Ltd | 154 Cr. | 483 | 1,100/463 | 25.2 | 337 | 0.00 % | 16.1 % | 13.6 % | 10.0 |
| Deccan Bearings Ltd | 620 Cr. | 310 | 310/81.2 | 8.79 | 0.00 % | 127 % | 127 % | 10.0 | |
| Benara Bearings & Pistons Ltd | 17.0 Cr. | 9.60 | 21.0/8.94 | 4.73 | 0.00 % | 26.1 % | 512 % | 10.0 | |
| Austin Engineering Company Ltd | 45.5 Cr. | 131 | 206/128 | 10.4 | 198 | 0.00 % | 8.04 % | 6.00 % | 10.0 |
| Timken India Ltd | 22,156 Cr. | 2,946 | 3,576/2,200 | 48.7 | 368 | 1.22 % | 20.9 % | 17.0 % | 10.0 |
| Industry Average | 13,437.14 Cr | 1,094.84 | 29.64 | 216.54 | 0.67% | 31.75% | 82.59% | 7.22 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 695 | 609 | 803 | 718 | 682 | 612 | 898 | 784 | 753 | 671 | 940 | 809 | 773 |
| Expenses | 563 | 506 | 650 | 582 | 546 | 510 | 699 | 643 | 620 | 565 | 730 | 666 | 635 |
| Operating Profit | 132 | 104 | 153 | 136 | 136 | 102 | 199 | 141 | 133 | 107 | 210 | 142 | 138 |
| OPM % | 19% | 17% | 19% | 19% | 20% | 17% | 22% | 18% | 18% | 16% | 22% | 18% | 18% |
| Other Income | 22 | 14 | 7 | 9 | 10 | 11 | 11 | 12 | 12 | 13 | 14 | 10 | 10 |
| Interest | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 22 | 22 | 21 | 21 | 21 | 21 | 22 | 22 | 21 | 21 | 21 | 21 | 27 |
| Profit before tax | 131 | 95 | 137 | 123 | 124 | 91 | 187 | 130 | 124 | 98 | 202 | 130 | 121 |
| Tax % | 26% | 26% | 24% | 27% | 25% | 26% | 24% | 26% | 27% | 24% | 7% | 20% | 26% |
| Net Profit | 98 | 71 | 105 | 90 | 93 | 68 | 141 | 96 | 90 | 74 | 187 | 104 | 89 |
| EPS in Rs | 12.98 | 9.38 | 13.89 | 11.98 | 12.37 | 8.98 | 18.80 | 12.80 | 11.96 | 9.88 | 24.84 | 13.86 | 11.89 |
Last Updated: December 28, 2025, 7:34 pm
Below is a detailed analysis of the quarterly data for Timken India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 773.00 Cr.. The value appears to be declining and may need further review. It has decreased from 809.00 Cr. (Jun 2025) to 773.00 Cr., marking a decrease of 36.00 Cr..
- For Expenses, as of Sep 2025, the value is 635.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 666.00 Cr. (Jun 2025) to 635.00 Cr., marking a decrease of 31.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 138.00 Cr.. The value appears to be declining and may need further review. It has decreased from 142.00 Cr. (Jun 2025) to 138.00 Cr., marking a decrease of 4.00 Cr..
- For OPM %, as of Sep 2025, the value is 18.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 18.00%.
- For Other Income, as of Sep 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 10.00 Cr..
- For Interest, as of Sep 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 1.00 Cr..
- For Depreciation, as of Sep 2025, the value is 27.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 21.00 Cr. (Jun 2025) to 27.00 Cr., marking an increase of 6.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 121.00 Cr.. The value appears to be declining and may need further review. It has decreased from 130.00 Cr. (Jun 2025) to 121.00 Cr., marking a decrease of 9.00 Cr..
- For Tax %, as of Sep 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 20.00% (Jun 2025) to 26.00%, marking an increase of 6.00%.
- For Net Profit, as of Sep 2025, the value is 89.00 Cr.. The value appears to be declining and may need further review. It has decreased from 104.00 Cr. (Jun 2025) to 89.00 Cr., marking a decrease of 15.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 11.89. The value appears to be declining and may need further review. It has decreased from 13.86 (Jun 2025) to 11.89, marking a decrease of 1.97.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:29 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 719 | 926 | 1,042 | 1,056 | 1,233 | 1,664 | 1,618 | 1,411 | 2,203 | 2,807 | 2,910 | 3,148 | 3,193 |
| Expenses | 646 | 792 | 880 | 898 | 1,070 | 1,375 | 1,254 | 1,159 | 1,692 | 2,246 | 2,337 | 2,556 | 2,596 |
| Operating Profit | 73 | 134 | 162 | 158 | 163 | 289 | 363 | 252 | 511 | 560 | 572 | 592 | 597 |
| OPM % | 10% | 14% | 16% | 15% | 13% | 17% | 22% | 18% | 23% | 20% | 20% | 19% | 19% |
| Other Income | 10 | 6 | 3 | 10 | 21 | 16 | 23 | 20 | 14 | 53 | 41 | 50 | 47 |
| Interest | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 2 | 3 | 4 | 4 | 4 |
| Depreciation | 16 | 17 | 22 | 29 | 43 | 79 | 77 | 75 | 84 | 87 | 85 | 85 | 89 |
| Profit before tax | 66 | 122 | 142 | 138 | 140 | 224 | 306 | 195 | 438 | 524 | 524 | 553 | 550 |
| Tax % | 32% | 34% | 35% | 30% | 34% | 34% | 20% | 27% | 25% | 25% | 25% | 19% | |
| Net Profit | 45 | 81 | 92 | 97 | 92 | 149 | 246 | 143 | 327 | 391 | 392 | 447 | 455 |
| EPS in Rs | 6.58 | 11.87 | 13.50 | 14.29 | 13.53 | 19.76 | 32.72 | 19.04 | 43.49 | 51.95 | 52.13 | 59.48 | 60.47 |
| Dividend Payout % | 99% | 25% | 7% | 7% | 7% | 5% | 153% | 8% | 3% | 3% | 5% | 61% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 80.00% | 13.58% | 5.43% | -5.15% | 61.96% | 65.10% | -41.87% | 128.67% | 19.57% | 0.26% | 14.03% |
| Change in YoY Net Profit Growth (%) | 0.00% | -66.42% | -8.15% | -10.59% | 67.11% | 3.14% | -106.97% | 170.54% | -109.10% | -19.32% | 13.77% |
Timken India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 14% |
| 3 Years: | 13% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 13% |
| 3 Years: | 11% |
| TTM: | 14% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 20% |
| 3 Years: | -4% |
| 1 Year: | -24% |
| Return on Equity | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 18% |
| 3 Years: | 18% |
| Last Year: | 17% |
Last Updated: September 5, 2025, 1:46 pm
Balance Sheet
Last Updated: December 4, 2025, 2:07 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 68 | 68 | 68 | 68 | 68 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 |
| Reserves | 314 | 370 | 462 | 550 | 634 | 1,266 | 1,501 | 1,268 | 1,582 | 1,962 | 2,342 | 2,770 | 2,693 |
| Borrowings | 3 | 3 | 4 | 8 | 16 | 23 | 24 | 35 | 32 | 31 | 25 | 17 | 15 |
| Other Liabilities | 114 | 144 | 168 | 251 | 261 | 411 | 377 | 510 | 505 | 489 | 545 | 564 | 598 |
| Total Liabilities | 500 | 585 | 702 | 877 | 979 | 1,775 | 1,977 | 1,888 | 2,194 | 2,557 | 2,988 | 3,425 | 3,382 |
| Fixed Assets | 97 | 107 | 137 | 231 | 251 | 795 | 748 | 818 | 860 | 843 | 853 | 809 | 1,265 |
| CWIP | 26 | 27 | 21 | 58 | 54 | 64 | 157 | 97 | 50 | 53 | 104 | 592 | 241 |
| Investments | 23 | 17 | 38 | 91 | 55 | 176 | 13 | 0 | 99 | 236 | 161 | 117 | 120 |
| Other Assets | 354 | 435 | 506 | 498 | 619 | 741 | 1,060 | 973 | 1,185 | 1,424 | 1,870 | 1,908 | 1,756 |
| Total Assets | 500 | 585 | 702 | 877 | 979 | 1,775 | 1,977 | 1,888 | 2,194 | 2,557 | 2,988 | 3,425 | 3,382 |
Below is a detailed analysis of the balance sheet data for Timken India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 75.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 75.00 Cr..
- For Reserves, as of Sep 2025, the value is 2,693.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,770.00 Cr. (Mar 2025) to 2,693.00 Cr., marking a decrease of 77.00 Cr..
- For Borrowings, as of Sep 2025, the value is 15.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 17.00 Cr. (Mar 2025) to 15.00 Cr., marking a decrease of 2.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 598.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 564.00 Cr. (Mar 2025) to 598.00 Cr., marking an increase of 34.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 3,382.00 Cr.. The value appears to be improving (decreasing). It has decreased from 3,425.00 Cr. (Mar 2025) to 3,382.00 Cr., marking a decrease of 43.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,265.00 Cr.. The value appears strong and on an upward trend. It has increased from 809.00 Cr. (Mar 2025) to 1,265.00 Cr., marking an increase of 456.00 Cr..
- For CWIP, as of Sep 2025, the value is 241.00 Cr.. The value appears to be declining and may need further review. It has decreased from 592.00 Cr. (Mar 2025) to 241.00 Cr., marking a decrease of 351.00 Cr..
- For Investments, as of Sep 2025, the value is 120.00 Cr.. The value appears strong and on an upward trend. It has increased from 117.00 Cr. (Mar 2025) to 120.00 Cr., marking an increase of 3.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,756.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,908.00 Cr. (Mar 2025) to 1,756.00 Cr., marking a decrease of 152.00 Cr..
- For Total Assets, as of Sep 2025, the value is 3,382.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,425.00 Cr. (Mar 2025) to 3,382.00 Cr., marking a decrease of 43.00 Cr..
Notably, the Reserves (2,693.00 Cr.) exceed the Borrowings (15.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 70.00 | 131.00 | 158.00 | 150.00 | 147.00 | 266.00 | 339.00 | 217.00 | 479.00 | 529.00 | 547.00 | 575.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 75 | 69 | 68 | 66 | 66 | 66 | 66 | 96 | 89 | 75 | 82 | 81 |
| Inventory Days | 112 | 110 | 108 | 111 | 121 | 125 | 124 | 171 | 171 | 125 | 142 | 124 |
| Days Payable | 60 | 57 | 65 | 92 | 97 | 92 | 92 | 156 | 100 | 76 | 82 | 76 |
| Cash Conversion Cycle | 128 | 122 | 110 | 85 | 90 | 99 | 98 | 112 | 160 | 124 | 142 | 129 |
| Working Capital Days | 104 | 98 | 91 | 70 | 96 | 80 | 74 | 86 | 117 | 102 | 111 | 107 |
| ROCE % | 19% | 30% | 30% | 24% | 21% | 22% | 21% | 13% | 29% | 28% | 23% | 21% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| HDFC Mid Cap Fund | 2,193,640 | 0.75 | 691.96 | 2,150,287 | 2025-12-14 00:38:48 | 2.02% |
| HDFC Small Cap Fund | 1,715,839 | 1.42 | 541.24 | 1,635,876 | 2025-12-14 13:37:58 | 4.89% |
| Nippon India Small Cap Fund | 1,184,218 | 0.54 | 373.55 | 1,134,218 | 2025-11-02 18:14:38 | 4.41% |
| Mirae Asset Large Cap Fund | 805,394 | 0.61 | 254.05 | 682,131 | 2025-10-30 01:21:09 | 18.07% |
| Nippon India Multi Cap Fund | 765,286 | 0.48 | 241.4 | N/A | N/A | N/A |
| Nippon India Growth Mid Cap Fund | 646,271 | 0.48 | 203.86 | N/A | N/A | N/A |
| Mirae Asset ELSS Tax Saver Fund | 584,528 | 0.68 | 184.38 | 469,585 | 2025-12-15 00:57:48 | 24.48% |
| SBI Large & Midcap Fund | 560,000 | 0.48 | 176.65 | 595,174 | 2025-10-30 01:21:09 | -5.91% |
| ICICI Prudential Smallcap Fund | 522,836 | 1.95 | 164.92 | 520,855 | 2025-12-14 01:36:52 | 0.38% |
| Invesco India Contra Fund | 480,033 | 0.74 | 151.42 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 59.48 | 52.13 | 51.95 | 43.49 | 19.03 |
| Diluted EPS (Rs.) | 59.48 | 52.13 | 51.95 | 43.49 | 19.03 |
| Cash EPS (Rs.) | 70.75 | 63.46 | 63.54 | 54.70 | 28.99 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 378.21 | 321.36 | 270.83 | 220.28 | 178.61 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 378.21 | 321.36 | 270.83 | 220.28 | 178.61 |
| Dividend / Share (Rs.) | 36.00 | 2.50 | 1.50 | 1.50 | 1.50 |
| Revenue From Operations / Share (Rs.) | 418.49 | 386.81 | 373.13 | 292.91 | 187.52 |
| PBDIT / Share (Rs.) | 85.32 | 81.52 | 81.57 | 69.79 | 36.08 |
| PBIT / Share (Rs.) | 74.05 | 70.19 | 69.97 | 58.58 | 26.12 |
| PBT / Share (Rs.) | 73.48 | 69.69 | 69.60 | 58.25 | 25.93 |
| Net Profit / Share (Rs.) | 59.48 | 52.13 | 51.95 | 43.49 | 19.03 |
| PBDIT Margin (%) | 20.38 | 21.07 | 21.86 | 23.82 | 19.23 |
| PBIT Margin (%) | 17.69 | 18.14 | 18.75 | 19.99 | 13.93 |
| PBT Margin (%) | 17.55 | 18.01 | 18.65 | 19.88 | 13.82 |
| Net Profit Margin (%) | 14.21 | 13.47 | 13.92 | 14.84 | 10.15 |
| Return on Networth / Equity (%) | 15.72 | 16.22 | 19.18 | 19.74 | 10.65 |
| Return on Capital Employeed (%) | 19.11 | 20.99 | 24.71 | 25.06 | 13.54 |
| Return On Assets (%) | 13.06 | 13.12 | 15.28 | 14.91 | 7.58 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 |
| Asset Turnover Ratio (%) | 0.98 | 1.05 | 1.18 | 1.08 | 0.72 |
| Current Ratio (X) | 3.82 | 3.91 | 3.77 | 2.89 | 2.16 |
| Quick Ratio (X) | 2.56 | 2.50 | 2.44 | 1.61 | 1.32 |
| Inventory Turnover Ratio (X) | 4.80 | 4.71 | 1.64 | 1.58 | 1.36 |
| Dividend Payout Ratio (NP) (%) | 4.20 | 2.87 | 2.88 | 3.44 | 262.63 |
| Dividend Payout Ratio (CP) (%) | 3.53 | 2.36 | 2.36 | 2.74 | 172.44 |
| Earning Retention Ratio (%) | 95.80 | 97.13 | 97.12 | 96.56 | -162.63 |
| Cash Earning Retention Ratio (%) | 96.47 | 97.64 | 97.64 | 97.26 | -72.44 |
| Interest Coverage Ratio (X) | 149.64 | 161.83 | 218.11 | 214.54 | 188.33 |
| Interest Coverage Ratio (Post Tax) (X) | 105.31 | 104.49 | 139.91 | 134.68 | 100.36 |
| Enterprise Value (Cr.) | 20293.77 | 21146.70 | 20763.57 | 16203.61 | 9597.83 |
| EV / Net Operating Revenue (X) | 6.45 | 7.27 | 7.40 | 7.35 | 6.80 |
| EV / EBITDA (X) | 31.62 | 34.49 | 33.84 | 30.87 | 35.37 |
| MarketCap / Net Operating Revenue (X) | 6.57 | 7.38 | 7.45 | 7.35 | 6.90 |
| Retention Ratios (%) | 95.79 | 97.12 | 97.11 | 96.55 | -162.63 |
| Price / BV (X) | 7.27 | 8.88 | 10.26 | 9.77 | 7.25 |
| Price / Net Operating Revenue (X) | 6.57 | 7.38 | 7.45 | 7.35 | 6.90 |
| EarningsYield | 0.02 | 0.01 | 0.01 | 0.02 | 0.01 |
After reviewing the key financial ratios for Timken India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 59.48. This value is within the healthy range. It has increased from 52.13 (Mar 24) to 59.48, marking an increase of 7.35.
- For Diluted EPS (Rs.), as of Mar 25, the value is 59.48. This value is within the healthy range. It has increased from 52.13 (Mar 24) to 59.48, marking an increase of 7.35.
- For Cash EPS (Rs.), as of Mar 25, the value is 70.75. This value is within the healthy range. It has increased from 63.46 (Mar 24) to 70.75, marking an increase of 7.29.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 378.21. It has increased from 321.36 (Mar 24) to 378.21, marking an increase of 56.85.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 378.21. It has increased from 321.36 (Mar 24) to 378.21, marking an increase of 56.85.
- For Dividend / Share (Rs.), as of Mar 25, the value is 36.00. This value exceeds the healthy maximum of 3. It has increased from 2.50 (Mar 24) to 36.00, marking an increase of 33.50.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 418.49. It has increased from 386.81 (Mar 24) to 418.49, marking an increase of 31.68.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 85.32. This value is within the healthy range. It has increased from 81.52 (Mar 24) to 85.32, marking an increase of 3.80.
- For PBIT / Share (Rs.), as of Mar 25, the value is 74.05. This value is within the healthy range. It has increased from 70.19 (Mar 24) to 74.05, marking an increase of 3.86.
- For PBT / Share (Rs.), as of Mar 25, the value is 73.48. This value is within the healthy range. It has increased from 69.69 (Mar 24) to 73.48, marking an increase of 3.79.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 59.48. This value is within the healthy range. It has increased from 52.13 (Mar 24) to 59.48, marking an increase of 7.35.
- For PBDIT Margin (%), as of Mar 25, the value is 20.38. This value is within the healthy range. It has decreased from 21.07 (Mar 24) to 20.38, marking a decrease of 0.69.
- For PBIT Margin (%), as of Mar 25, the value is 17.69. This value is within the healthy range. It has decreased from 18.14 (Mar 24) to 17.69, marking a decrease of 0.45.
- For PBT Margin (%), as of Mar 25, the value is 17.55. This value is within the healthy range. It has decreased from 18.01 (Mar 24) to 17.55, marking a decrease of 0.46.
- For Net Profit Margin (%), as of Mar 25, the value is 14.21. This value exceeds the healthy maximum of 10. It has increased from 13.47 (Mar 24) to 14.21, marking an increase of 0.74.
- For Return on Networth / Equity (%), as of Mar 25, the value is 15.72. This value is within the healthy range. It has decreased from 16.22 (Mar 24) to 15.72, marking a decrease of 0.50.
- For Return on Capital Employeed (%), as of Mar 25, the value is 19.11. This value is within the healthy range. It has decreased from 20.99 (Mar 24) to 19.11, marking a decrease of 1.88.
- For Return On Assets (%), as of Mar 25, the value is 13.06. This value is within the healthy range. It has decreased from 13.12 (Mar 24) to 13.06, marking a decrease of 0.06.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.98. It has decreased from 1.05 (Mar 24) to 0.98, marking a decrease of 0.07.
- For Current Ratio (X), as of Mar 25, the value is 3.82. This value exceeds the healthy maximum of 3. It has decreased from 3.91 (Mar 24) to 3.82, marking a decrease of 0.09.
- For Quick Ratio (X), as of Mar 25, the value is 2.56. This value exceeds the healthy maximum of 2. It has increased from 2.50 (Mar 24) to 2.56, marking an increase of 0.06.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.80. This value is within the healthy range. It has increased from 4.71 (Mar 24) to 4.80, marking an increase of 0.09.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 4.20. This value is below the healthy minimum of 20. It has increased from 2.87 (Mar 24) to 4.20, marking an increase of 1.33.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 3.53. This value is below the healthy minimum of 20. It has increased from 2.36 (Mar 24) to 3.53, marking an increase of 1.17.
- For Earning Retention Ratio (%), as of Mar 25, the value is 95.80. This value exceeds the healthy maximum of 70. It has decreased from 97.13 (Mar 24) to 95.80, marking a decrease of 1.33.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 96.47. This value exceeds the healthy maximum of 70. It has decreased from 97.64 (Mar 24) to 96.47, marking a decrease of 1.17.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 149.64. This value is within the healthy range. It has decreased from 161.83 (Mar 24) to 149.64, marking a decrease of 12.19.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 105.31. This value is within the healthy range. It has increased from 104.49 (Mar 24) to 105.31, marking an increase of 0.82.
- For Enterprise Value (Cr.), as of Mar 25, the value is 20,293.77. It has decreased from 21,146.70 (Mar 24) to 20,293.77, marking a decrease of 852.93.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 6.45. This value exceeds the healthy maximum of 3. It has decreased from 7.27 (Mar 24) to 6.45, marking a decrease of 0.82.
- For EV / EBITDA (X), as of Mar 25, the value is 31.62. This value exceeds the healthy maximum of 15. It has decreased from 34.49 (Mar 24) to 31.62, marking a decrease of 2.87.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 6.57. This value exceeds the healthy maximum of 3. It has decreased from 7.38 (Mar 24) to 6.57, marking a decrease of 0.81.
- For Retention Ratios (%), as of Mar 25, the value is 95.79. This value exceeds the healthy maximum of 70. It has decreased from 97.12 (Mar 24) to 95.79, marking a decrease of 1.33.
- For Price / BV (X), as of Mar 25, the value is 7.27. This value exceeds the healthy maximum of 3. It has decreased from 8.88 (Mar 24) to 7.27, marking a decrease of 1.61.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 6.57. This value exceeds the healthy maximum of 3. It has decreased from 7.38 (Mar 24) to 6.57, marking a decrease of 0.81.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Timken India Ltd:
- Net Profit Margin: 14.21%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 19.11% (Industry Average ROCE: 31.75%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 15.72% (Industry Average ROE: 82.59%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 105.31
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.56
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 48.7 (Industry average Stock P/E: 29.64)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 14.21%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Bearings | No. 39-42, Electronic City, Phase II, Hosur Road, Bengaluru Karnataka 560100 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Sanjay Koul | Chairman & Managing Director |
| Mr. Avishrant Keshava | Whole Time Director |
| Mr. Ajay Sood | Independent Director |
| Mr. George J Ollapally | Independent Director |
| Dr. Lakshmi Lingam | Independent Director |
| Mrs. Soumitra Hazra | Independent Director |
| Mr. Douglas Smith | Director |
| Mr. Hansal Patel | Director |
FAQ
What is the intrinsic value of Timken India Ltd?
Timken India Ltd's intrinsic value (as of 10 January 2026) is ₹2467.07 which is 16.26% lower the current market price of ₹2,946.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹22,156 Cr. market cap, FY2025-2026 high/low of ₹3,576/2,200, reserves of ₹2,693 Cr, and liabilities of ₹3,382 Cr.
What is the Market Cap of Timken India Ltd?
The Market Cap of Timken India Ltd is 22,156 Cr..
What is the current Stock Price of Timken India Ltd as on 10 January 2026?
The current stock price of Timken India Ltd as on 10 January 2026 is ₹2,946.
What is the High / Low of Timken India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Timken India Ltd stocks is ₹3,576/2,200.
What is the Stock P/E of Timken India Ltd?
The Stock P/E of Timken India Ltd is 48.7.
What is the Book Value of Timken India Ltd?
The Book Value of Timken India Ltd is 368.
What is the Dividend Yield of Timken India Ltd?
The Dividend Yield of Timken India Ltd is 1.22 %.
What is the ROCE of Timken India Ltd?
The ROCE of Timken India Ltd is 20.9 %.
What is the ROE of Timken India Ltd?
The ROE of Timken India Ltd is 17.0 %.
What is the Face Value of Timken India Ltd?
The Face Value of Timken India Ltd is 10.0.